Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Other
Tramadol is a centrally acting synthetic opioid analgesic and serotonin-norepinephrine reuptake inhibitor (SNRI) used to manage moderate to moderately severe pain in adults. It is classified as a Schedule IV controlled substance due to its potential for misuse and addiction.
Name
Tramadol
Raw Name
TRAMADOL HYDROCHLORIDE
Category
Other
Salt Form
Hydrochloride
Drug Count
5
Variant Count
147
Last Verified
February 17, 2026
RxCUI
835603, 833711, 1148478, 1148485, 1148489, 1148482, 1148487, 1148491, 833709, 833713, 836395, 2179635, 2670390, 2692878, 2395808, 1946527, 1946525, 1946529
UNII
9N7R477WCK, 362O9ITL9D
About Tramadol
Tramadol is a centrally acting synthetic opioid analgesic and serotonin-norepinephrine reuptake inhibitor (SNRI) used to manage moderate to moderately severe pain in adults. It is classified as a Schedule IV controlled substance due to its potential for misuse and addiction.
Detailed information about Tramadol
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Tramadol.
Tramadol is a unique, centrally acting synthetic analgesic (pain-relieving) medication. While it is chemically classified as an opioid, it is often described as an 'atypical' opioid because of its dual mechanism of action. It was first developed by the German pharmaceutical company Grünenthal GmbH in the late 1970s and received FDA approval in the United States in 1995 under the brand name Ultram. Since its introduction, Tramadol has become one of the most widely prescribed medications for the management of moderate to moderately severe chronic and acute pain.
Tramadol belongs to a class of drugs called opioid agonists, but it also functions as a serotonin-norepinephrine reuptake inhibitor (SNRI). This dual nature allows it to address pain through two distinct pathways in the central nervous system (CNS). In the United States, the Drug Enforcement Administration (DEA) classifies Tramadol as a Schedule IV controlled substance, reflecting its potential for abuse, addiction, and diversion, though this risk is generally considered lower than that of Schedule II opioids like oxycodone or morphine. Despite this, healthcare providers must exercise caution when prescribing it, particularly to patients with a history of substance use disorders.
To understand how Tramadol works, one must look at its two-fold impact on the human nervous system.
The pharmacokinetics of Tramadol are complex, largely due to its reliance on metabolic conversion to become fully effective.
Tramadol is FDA-approved for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Tramadol is available in several formulations to suit different clinical needs:
> Important: Only your healthcare provider can determine if Tramadol is right for your specific condition. A thorough evaluation of your medical history, including any history of respiratory issues or substance use, is necessary before beginning treatment.
Dosage for Tramadol must be individualized based on the severity of the pain, the patient's response, and prior analgesic experience. Healthcare providers typically follow the principle of 'start low and go slow' to minimize side effects.
Tramadol is strictly contraindicated (must not be used) in children younger than 12 years of age. Furthermore, it is contraindicated in children younger than 18 years of age following surgery to remove the tonsils or adenoids (tonsillectomy/adenoidectomy). This is due to the risk of life-threatening respiratory depression, particularly in children who may be 'ultra-rapid metabolizers' of the drug.
In patients with a creatinine clearance (CrCl) of less than 30 mL/min, the dosing interval for immediate-release Tramadol should be increased to every 12 hours, and the maximum daily dose should not exceed 200 mg. Extended-release formulations are generally not recommended for patients with severe renal impairment.
For patients with severe hepatic (liver) impairment (e.g., Child-Pugh Class C), the recommended dose of immediate-release Tramadol is 50 mg every 12 hours. Extended-release products are not recommended for use in patients with severe hepatic impairment due to the unpredictable nature of drug metabolism in these individuals.
Patients over the age of 65 are at a higher risk of side effects, particularly respiratory depression and falls. For those over 75 years of age, the total daily dose of immediate-release Tramadol should not exceed 300 mg. Caution is advised when titrating the dose in this population.
Tramadol should be taken exactly as prescribed by your healthcare provider.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to make up for a missed one, as this increases the risk of respiratory depression and seizures.
An overdose of Tramadol is a medical emergency. Symptoms include pinpoint pupils, severe drowsiness, cold and clammy skin, muscle flaccidity, and slowed or stopped breathing. A unique feature of Tramadol overdose is the high risk of seizures, which may occur even without respiratory depression. If an overdose is suspected, call 911 or local emergency services immediately. Naloxone (Narcan) may be administered by emergency responders, though it may only partially reverse the effects and can increase the risk of seizures.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking the medication without medical guidance, as sudden discontinuation can lead to withdrawal symptoms.
Most patients taking Tramadol will experience some level of side effects, particularly during the first few days of treatment as the body adjusts to the medication. Common side effects include:
> Warning: Stop taking Tramadol and call your doctor or emergency services immediately if you experience any of the following:
Prolonged use of Tramadol can lead to physical dependence and tolerance, meaning higher doses are needed to achieve the same pain relief. It can also lead to 'Opioid-Induced Hyperalgesia,' where the patient becomes more sensitive to pain over time. Chronic use may also affect hormone levels, potentially leading to decreased libido, infertility, or osteoporosis.
The FDA has issued several 'Black Box' warnings for Tramadol—the highest level of warning for a prescription drug:
Report any unusual symptoms to your healthcare provider immediately. Monitoring by a medical professional is essential throughout the duration of Tramadol therapy.
Tramadol is a potent medication that requires strict adherence to safety protocols. It is not a typical 'over-the-counter' pain reliever and carries significant risks if used improperly. Patients must be screened for a history of substance abuse, respiratory disease, and seizure disorders before starting therapy.
As mandated by the FDA, Tramadol labels contain several critical warnings. These include the risk of Addiction, Abuse, and Misuse, which can occur even at recommended doses. There is also a warning for Life-Threatening Respiratory Depression, particularly during the first 24 to 72 hours of treatment or after a dose increase. Furthermore, the Neonatal Opioid Withdrawal Syndrome warning highlights that long-term use during pregnancy can lead to a withdrawal syndrome in the infant that may be fatal if not recognized and treated. Lastly, the Cytochrome P450 2D6 Interaction warning notes that individuals who are ultra-rapid metabolizers of Tramadol can experience life-threatening respiratory depression due to the rapid conversion of the drug to its more potent M1 metabolite.
Healthcare providers will typically perform the following monitoring:
Tramadol may impair the mental or physical abilities required for performing potentially dangerous tasks such as driving a car or operating machinery. This effect is most pronounced when starting the medication or when the dose is increased. Do not engage in these activities until you know how Tramadol affects you.
Do not consume alcohol while taking Tramadol. Alcohol can dangerously increase the sedative effects of Tramadol and significantly increase the risk of life-threatening respiratory depression, coma, and death.
Do not stop taking Tramadol suddenly if you have been taking it for more than a few days. Abruptly stopping can lead to withdrawal symptoms, including anxiety, sweating, insomnia, rigors, pain, nausea, tremors, and, in rare cases, hallucinations. Your doctor will provide a tapering schedule to gradually reduce the dose.
> Important: Discuss all your medical conditions, especially any history of head injury, seizures, or breathing problems, with your healthcare provider before starting Tramadol.
Certain medications should never be used in combination with Tramadol due to the risk of fatal outcomes:
Tramadol does not typically interfere with standard laboratory tests. However, it will result in a positive result for opioids on many routine urine drug screens. If you are undergoing a workplace drug test, you must disclose your valid prescription for Tramadol.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, as the dual-action nature of Tramadol makes it highly susceptible to drug-drug interactions.
In certain circumstances, the risks of Tramadol use clearly outweigh any potential benefits. Tramadol must NEVER be used in the following cases:
These conditions require a careful risk-benefit analysis by a healthcare provider:
Patients who have experienced anaphylactic reactions to codeine or other opiate analgesics may be at an increased risk of a similar reaction to Tramadol. While it is not a direct derivative of opium, its structural similarities and its interaction with opioid receptors mean that cross-sensitivity is a clinical concern.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of substance abuse or mental health conditions, before prescribing Tramadol.
Tramadol is generally not recommended during pregnancy. It is classified as a medication that should only be used if the potential benefit justifies the potential risk to the fetus. Prolonged use during pregnancy can lead to Neonatal Opioid Withdrawal Syndrome (NOWS), a life-threatening condition where the baby is born dependent on the drug. Symptoms in the newborn include irritability, hyperactivity, abnormal sleep patterns, high-pitched cry, tremor, vomiting, diarrhea, and failure to gain weight. There is no definitive evidence of teratogenicity (birth defects) in humans, but animal studies have shown some evidence of fetal toxicity at high doses.
Tramadol and its active metabolite (M1) are excreted into breast milk. While the amount is generally low, there is a risk of serious adverse effects in the nursing infant, including excess sleepiness, difficulty breastfeeding, or serious breathing problems. The FDA recommends against the use of Tramadol while breastfeeding. If a nursing mother must take Tramadol, the infant must be monitored extremely closely for signs of sedation or respiratory distress.
As previously stated, Tramadol is contraindicated in all children under 12 and in those under 18 for certain post-surgical pain. The safety and effectiveness of Tramadol in pediatric patients have not been established for other uses. The primary concern is the unpredictable rate of metabolism in children, which can lead to rapid, fatal levels of the drug in the system.
In patients over 65, the clearance of Tramadol is reduced, leading to higher concentrations in the blood. This increases the risk of side effects, particularly constipation, dizziness, and confusion. Elderly patients are also at a significantly higher risk of falls and fractures while taking opioids. Dose selection should be cautious, usually starting at the low end of the dosing range.
Because the kidneys are the primary route of elimination for Tramadol and its metabolites, patients with renal impairment (CrCl < 30 mL/min) require a reduced dose and an increased dosing interval (e.g., 50-100 mg every 12 hours). Tramadol is only minimally removed by hemodialysis, so a supplemental dose after dialysis is usually not required.
In patients with severe hepatic cirrhosis, the metabolism of Tramadol is significantly slowed. The recommended dose for these patients is 50 mg every 12 hours. Extended-release products should be avoided entirely in this population as their release characteristics may be altered by liver dysfunction.
> Important: Special populations require individualized medical assessment and frequent monitoring to ensure the safe use of Tramadol.
Tramadol is a centrally acting analgesic with a dual mechanism. It acts as a weak mu-opioid receptor agonist. Its primary metabolite, O-desmethyltramadol (M1), has a significantly higher affinity for the mu-receptor, contributing to its analgesic effect. Additionally, Tramadol inhibits the neuronal reuptake of norepinephrine and enhances the release of serotonin while inhibiting its reuptake. This dual action modulates the pain signal both as it ascends to the brain and as the brain attempts to suppress it via descending pathways.
The analgesic effect of Tramadol begins approximately 30 to 60 minutes after oral administration and peaks within 2 to 3 hours. The duration of action for the immediate-release form is about 4 to 6 hours. Unlike traditional opioids, Tramadol at therapeutic doses has a smaller effect on respiratory rate and gastrointestinal motility, though these risks are still present and dose-dependent.
| Parameter | Value |
|---|---|
| Bioavailability | 75% (Single dose), 90% (Multiple doses) |
| Protein Binding | ~20% |
| Half-life | 6.3 hours (Tramadol), 7.4 hours (M1 Metabolite) |
| Tmax | 2 hours (IR), 12 hours (ER) |
| Metabolism | Hepatic (CYP2D6 and CYP3A4) |
| Excretion | Renal (90%), Fecal (10%) |
Tramadol is classified as an atypical opioid analgesic. It is distinct from phenanthrene opioids (like morphine) and phenylpiperidine opioids (like fentanyl). Its unique SNRI-like properties place it in a category of its own within the broader class of centrally acting analgesics.
Medications containing this ingredient
Common questions about Tramadol
Tramadol is primarily used to manage moderate to moderately severe pain in adults who require around-the-clock treatment. It is commonly prescribed for acute pain following surgery or for chronic conditions such as osteoarthritis when other non-opioid medications have failed. Because it works on both opioid receptors and neurotransmitters like serotonin, it is also sometimes used off-label for nerve pain. It is important to note that it should only be used when other, less potent pain relievers are not effective. Always follow your doctor's specific indications for use.
The most frequently reported side effects of Tramadol include dizziness, nausea, constipation, and headache. Many patients also experience drowsiness or a feeling of being 'lightheaded,' which is why caution is advised when driving. Sweating and dry mouth are also relatively common during the initial stages of treatment. Most of these side effects are mild and tend to diminish as your body becomes accustomed to the medication. However, if they persist or become bothersome, you should consult your healthcare provider for management strategies.
No, you should strictly avoid alcohol while taking Tramadol. Alcohol can significantly enhance the sedative effects of the medication, leading to dangerous levels of drowsiness and impaired coordination. More importantly, the combination of alcohol and Tramadol increases the risk of life-threatening respiratory depression, where breathing becomes too slow or stops entirely. This combination has been linked to fatal overdoses. Even small amounts of alcohol can be dangerous when combined with opioid medications.
Tramadol is generally not recommended during pregnancy unless the potential benefits outweigh the risks to the developing fetus. Long-term use of Tramadol during pregnancy can cause the baby to be born with Neonatal Opioid Withdrawal Syndrome (NOWS), which requires specialized medical treatment in a neonatal intensive care unit. There are also concerns about the drug's effect on fetal development, although human data is limited. If you are pregnant or planning to become pregnant, it is vital to discuss alternative pain management options with your doctor. Breastfeeding while taking Tramadol is also discouraged due to the risk of infant sedation.
For the immediate-release tablets, patients typically begin to feel pain relief within 30 to 60 minutes after taking the dose. The maximum effect is usually reached within 2 to 3 hours. Extended-release formulations are designed to release the medication slowly over 24 hours, so they may take longer to reach a peak effect but provide more consistent relief throughout the day. The speed at which it works can be influenced by individual metabolism and whether the drug is taken on an empty stomach. If you do not feel relief after the expected time, do not take an extra dose without consulting your doctor.
You should never stop taking Tramadol abruptly if you have been using it regularly for more than a few days. Sudden discontinuation can trigger withdrawal symptoms such as anxiety, sweating, insomnia, muscle aches, and tremors. In some cases, patients may experience more severe symptoms like panic attacks or hallucinations. To avoid this, your healthcare provider will usually implement a tapering schedule, gradually reducing your dose over several days or weeks. This allows your brain and body to adjust slowly to the absence of the medication.
If you miss a dose of Tramadol, take it as soon as you remember. However, if it is almost time for your next scheduled dose, you should skip the missed dose and continue with your regular dosing schedule. Never take two doses at once to make up for a missed one, as this significantly increases the risk of serious side effects like seizures or respiratory depression. If you are unsure about what to do after missing multiple doses, contact your pharmacist or healthcare provider for guidance. Consistency is key to effective pain management with this medication.
Weight gain is not a commonly reported side effect of Tramadol. In fact, some patients experience a decrease in appetite or nausea, which can lead to slight weight loss during short-term use. However, because Tramadol can cause drowsiness and fatigue, some patients may become less physically active, which could indirectly lead to weight gain over a long period. If you notice significant changes in your weight while taking Tramadol, it is important to discuss this with your doctor to rule out other underlying causes. Maintaining a balanced diet and light activity as permitted by your pain level is recommended.
Tramadol has a high potential for drug interactions, so it must be used cautiously with other medications. It is particularly dangerous when combined with other CNS depressants like benzodiazepines, or with medications that affect serotonin levels, such as SSRI or SNRI antidepressants. These combinations can lead to life-threatening conditions like respiratory depression or Serotonin Syndrome. You must provide your doctor with a complete list of all prescription drugs, over-the-counter medicines, and herbal supplements you are taking. Your pharmacist can also help screen for potential interactions before you start your first dose.
Yes, Tramadol is widely available as a generic medication in both immediate-release and extended-release formulations. Generic versions are typically much more affordable than brand-name versions like Ultram or ConZip and are required by the FDA to have the same active ingredient, strength, and effectiveness. Most insurance plans cover the generic version of Tramadol. When picking up your prescription, your pharmacist can confirm if a generic version is being dispensed. Regardless of whether you take the brand or generic, the safety precautions and potential side effects remain exactly the same.